Israeli chatbot could diagnose early Alzheimer’s disease

Hundreds of medicine are developed to handle Alzheimer’s disease, says Dr. Shahar Arzy, director of the computational neuropsychiatry laboratory at Hadassah Hebrew University Medical Center in Jerusalem. “Do you recognize what number are found effective? Zero.”But if patients could be diagnosed in the preclinical stages of the disease, perhaps some of the new biological medications showing excellent results in other domains of neurology could be effective when applied early enough in the course of Alzheimer’s disease.Arzy and his colleagues have developed a computer-based system to discover early signs of Alzheimer’s.Clara then uses machine learning to compare that information to a baseline so as to get a computer-based test tailored for the individual person who will diagnose every early Alzheimer’s.

Arzy’s team published research results in the Proceedings of the National Academy of Sciences and in the American Psychological Association’s journal Neuropsychology showing the method to be 95 percent accurate.Arzy's group published research results in the Proceedings of the National Academy of Sciences and in the American Psychological Association's journal Neuropsychology demonstrating the technique to be 95 percent exact.

For example, a patient may recollect both the death of US President John F. Kennedy and the appointment of Barack Obama however be confused about which came first. Or then again a patient may perceive their companion and specialist, however not have the option to recognize which individual is standing nearer.